SUMMARY Liver diseases are associated with complex haemostasis defects, in which platelets, coagulation, and fibrinolysis may all be affected. The low plasma concentrations of clottinlg factors often found can be the result of many changes such as impaired synthesis, increased catabolism due to intravascular coagulation, or alternate distribution.
Liver disease is associated with a complex haemostasis defect, in which platelets, coagulation, and fibrinolysis may all be affected.' In this study we describe the metabolism of human antithrombin III (AT III) in patients with chronic liver disease.
Antithrombin III neutralises thrombin and several other activated serine proteases of the coagulation system.23 Congenital or acquired AT III deficiencies are associated with recurrent thromboembolism. 46 Plasma concentrations of this physiological inhibitor of the coagulation system are low in severe chronic liver disease'-" and Tytgat et al have evidence for low grade diffuse intravascular coagulation."
I They found a shorter ,3 half life of radiolabelled fibrinogen in patients with liver disease, which could be prolonged by heparinisation.
Other studies have shown that selective correction of AT III activity with human AT III concentrate reverses the increased turnover of radiolabelled fibrinogen in these patients. '2 These observations indicate that decreased AT III activity contributes to a major part of the increased radiolabelled fibrinogen turnover. In order to Accepted for publication 23 November 1983 determine whether low plasma concentrations of AT III are due to impaired synthesis and/or low grade diffuse intravascular coagulation or alternate distribution, turnover studies are necessary using highly purified radiolabelled AT III. One study, '3 using radiolabelled AT III in patients with severe liver disease, showed normal /3 half life values. In this paper we report a further turnover study in patients with liver disease.
Material and methods SUBJECTS AND CLINICAL DETAILS
Twenty five patients with histologically proved chronic liver disease were studied. Twelve had micronodular cirrhosis due to alcoholism and nine had macronodular cirrhosis with positive hepatitis B surface antigen (HBsAg). One patient had cirrhosis and an associated hepatocellular carcinoma of the liver. Two patients had micronodular cirrhosis of unknown aetiology and one had Budd-Chiari syndrome. None of the patients was receiving anticoagulant therapy. All patients were studied as outpatients. Three patients had mild ascites.
The mean age was 47-3 yr. The mean weight was 523 524 80 ± 10-9 kg and 72 ± 6*7 kg in the micronodular and macronodular groups respectively. In the micronodular and macronodular cirrhosis groups there were two and three patients respectively with transaminase activities more than twice the upper limit of the normal range. Three patients in the micronodular cirrhosis group had alkaline phosphatase and y-glutamyltransferase activities more than twice the upper limit of the normal range. The mean albumin concentration of the whole group of patients was 38-3 ± 6-10 g/l. (micronodular cirrhosis 35*8 ± 6 5 g/l; macronodular 41-1 ± 5'4 g/l; normal 35-50 g/l). Nine healthy male volunteers were screened as controls.
PREPARATION OF RADIOACTIVE TRACER
The AT III was purified from HBsAg negative plasma. '4 One unit of AT III was defined as the thrombin inactivity present in 1 ml of pooled plasma (40 donors, M:F = 1:1). The specific heparin cofactor activity was 5-6 U/mg per absorbency unit at 280 nm. SDS-polyacrylamide gel electrophoresis '5 showed one band with a molecular weight of about 67 000 daltons when stained for protein with (Fig. 1) .
Gel filtration of a mixture of '25I-AT III and normal human plasma on Sephadex G100 showed one radioactivity peak with a similar elution pattern and biological activity as AT III antigen.
The specific activity of the preparation after labelling was unchanged.
Turnover data obtained with this preparation can therefore be assumed to reflect that of the total body AT 
Results

RESULTS OF COAGULATION AND FIBRINOLYTIC DATA
The mean values of the activated partial thromboplastic time and the prothrombin and thrombin times of the micronodular and macronodular groups were prolonged by 11, 2, and 4 seconds respectively. The mean plasma concentrations of factors V and VII were 0-69 ± 0-23 U/ml and 0.50 0-22 U/ml respectively (n = 11) (normal values 0-70-1*4 U/ ml). In the macronodular group the mean a value was not significantly different from the control group.
The ,B half life was 52-7 h, which was significantly shorter compared with normal subjects (58&6 h) (p < 0-025 Student' s t test and Wilcoxon).
The transcapillary influx rate constant (k2 l) (0109 h-') was also significantly increased compared with normal subjects (0-071 h-') (p < 0-005 Wilcoxon). We found no correlation between the /8 half life and the plasma AT III level in either group; this has also been reported in two other studies.' " 45 In both groups the mean value of the fractional catabolic rate constant k, 0 was similar to the control group. This suggests that there was no increased consumption in the central compartment. In addition, we found no correlation in either group between the fractional catabolic rate constant and plasma AT III values; this was also seen in two other studies' " 45 but again not in the study of Chan et al. '3 The shorter 83 half life with a normal fractional catabolic rate constant must be due to a change in transcapillary efflux:influx ratio.
We found significantly raised values of the transcapillary influx rate constant (k2,) in both groups (0.172 h-' and 0-108h-' respectively), whereas the mean value of the transcapillary efflux rate constant (k, 2) was only significantly raised in the micronodular'group compared with the control group, although the k2,l was always higher than the k, 2.
Similar results have been found by others"45 not only for coagulation proteins but also for radiolabelled albumin.4647 Although these investigators noticed that the k, was higher than the k, 2 in these patients, these data were not discussed. We think that this phenomenon could be specific to this disease. At least the shortened /8 half life can be explained by alternate flux ratio. In addition, we found a reasonable correlation between the k2,1 and the apparent distributing volume (Vd).
It is unlikely that the high apparent Vd is a result of ascites as the apparent volume sometimes increases more than the total body volume and some investigators who injected radiolabelled fibrinogen intraperitoneally recovered only 4-8% of the injected doses in the circulation." Only two exceptions to this general pattern were found. One was the patient with primary liver cell carcinoma and the other was a patient with micronodular cirrhosis with an extremely low plasma AT III concentration (0-24 U/ml). In both patients a raised fractional catabolic rate constant was found suggesting consumption in the central compartment, which was substantiated by the occurrence of high concentrations of fibrinogen degradation products and clinical signs of diffuse intravascular coagulation in the patient with primary liver cell carcinoma at necropsy.
Unlike the other patients the value of the transcapillary efflux rate constant (k, 2) was higher than the influx constant (k ,). Chan 
